Monurol (Fosfomycin Trometamol)

Fosfomycin Trometamol, the active ingredient in Monurol, is a phosphonic acid antibiotic presented as a 3 g granules for oral solution for oral use. It treats uncomplicated urinary tract infections caused by susceptible bacteria in adult patients.

GNH USA supplies Monurol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Monurol is indicated for bacterial infections of the urinary tract, specifically targeting uncomplicated infections.

Uncomplicated urinary tract infections (UTIs): provides a single‑dose eradication of susceptible uropathogens, relieving symptoms and reducing bacterial load. Acute uncomplicated cystitis: achieves microbiological cure in most female patients with a single oral dose. Prophylaxis of recurrent urinary tract infections: may be used intermittently to prevent recurrence in patients with a history of repeated UTIs.

Adverse reactions may occur with any antibiotic therapy. Most are mild and self‑limiting.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, usually transient. - Headache: mild cranial discomfort. - Abdominal pain: cramping or discomfort in the abdomen. - Dyspepsia: indigestion or heartburn. - Vomiting: occasional emesis.

Serious or Rare Side Effects: - Allergic reactions: rash, pruritus, or anaphylaxis. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Clostridioides difficile infection: colitis associated with antibiotic use. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Renal impairment: worsening kidney function in susceptible individuals. - Hematologic abnormalities: neutropenia or thrombocytopenia.

Before prescribing Monurol, consider patient‑specific factors and safety measures.

Renal function: assess severity of impairment and adjust use if necessary. Pregnancy: safety category unknown; avoid unless benefits outweigh potential risks. Breastfeeding: unknown excretion in milk; consider risk to infant. Allergy to fosfomycin: contraindicated in patients with known hypersensitivity. Drug interactions: review concomitant medications for potential effects on absorption or efficacy. Store at below 25°C: keep in the original pack, protect from moisture.

Fosfomycin may interact with other medicines, requiring attention to avoid reduced effectiveness or increased toxicity.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: may significantly decrease fosfomycin absorption. - Probenecid: can increase serum fosfomycin concentrations, raising risk of toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: potential potentiation of anticoagulant effect; monitor INR. - Oral contraceptives: possible reduction in hormonal efficacy; advise additional contraceptive measures. - Diabetes medications: monitor blood glucose as fosfomycin may affect glycemic control.